Cochrane Abstracts
Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Single or Combined Immune Checkpoint Inhibitors Compared to First‐line Platinum‐based Chemotherapy With or Without Bevacizumab for People With Advanced Non‐small Cell Lung Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433368/1/Single_or_combined_immune_checkpoint_inhibitors_compared_to_first‐line_platinum‐based_chemotherapy_with_or_without_bevacizumab_for_people_with_advanced_non‐small_cell_lung_cancer_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 04 October 2024.
Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433368/1/Single_or_combined_immune_checkpoint_inhibitors_compared_to_first‐line_platinum‐based_chemotherapy_with_or_without_bevacizumab_for_people_with_advanced_non‐small_cell_lung_cancer_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed October 4, 2024.
Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433368/1/Single_or_combined_immune_checkpoint_inhibitors_compared_to_first‐line_platinum‐based_chemotherapy_with_or_without_bevacizumab_for_people_with_advanced_non‐small_cell_lung_cancer_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Single or Combined Immune Checkpoint Inhibitors Compared to First‐line Platinum‐based Chemotherapy With or Without Bevacizumab for People With Advanced Non‐small Cell Lung Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 October 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433368/1/Single_or_combined_immune_checkpoint_inhibitors_compared_to_first‐line_platinum‐based_chemotherapy_with_or_without_bevacizumab_for_people_with_advanced_non‐small_cell_lung_cancer_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
ID - 433368
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433368/1/Single_or_combined_immune_checkpoint_inhibitors_compared_to_first‐line_platinum‐based_chemotherapy_with_or_without_bevacizumab_for_people_with_advanced_non‐small_cell_lung_cancer_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
